Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
11/1996
11/26/1996US5578591 Effective against grampositive and gramnegative organisms
11/26/1996US5578589 Method for suppressing an immunoresponse with an estradiol derivative-chlorambucil conjugate
11/26/1996US5578588 Nasal administration of a precursor
11/26/1996US5578587 Methods and compositions containing vitamin D compounds for improvement of skin conditions
11/26/1996US5578585 Pleuromutilin derivative complexes
11/26/1996US5578583 Microemulsions used as vehicles for carrying chemotherapeutic agents to neoplastic cells
11/26/1996US5578582 Methods of treating ischemia with C2, N6 -disubstituted adenosine derivatives
11/26/1996US5578579 Treatment of gastrointestinal disorders
11/26/1996US5578576 Nutrient solution for reducing side effects of nonsteroidal antiinflammatory drugs
11/26/1996US5578572 Anti-gram-positive bacterial methods and materials
11/26/1996US5578571 Cytostatic or cytotoxic combination of active substances for use in therapeutic procedures
11/26/1996US5578469 Process for preparing neotrehalose, and its uses
11/26/1996US5578334 Increasing the HDL level and the HDL/LDL ratio in human serum with fat blends
11/26/1996US5578323 Proteinoid carriers and methods for preparation and use thereof
11/26/1996US5578321 Controlled release formulation of diltiazem hydrochloride
11/26/1996US5578320 Method of dehydrating liposomes using protective sugars
11/26/1996US5578305 Methods and preparations for preventing adhesions to organs and parts of organs
11/26/1996US5578299 Rinse-off skin conditioner
11/26/1996US5578287 Three-step pretargeting methods using improved biotin-active agent
11/26/1996CA2113916C 6-chloro-5-fluoro-3-(2-thenoyl)-2-oxindole-1-carboxamide as an analgesic and anti-inflammatory agent
11/26/1996CA2078287C Nitroxides as protectors against oxidative stress
11/26/1996CA2069906C Uncharged morpholino-based polymers having achiral intersubunit linkages
11/26/1996CA2042870C Metal ion coordinated polyamine resins for the lowering of blood cholesterol
11/26/1996CA2033448C Antiherpes compositions and method of use
11/26/1996CA2027592C Solid pharmaceutical preparations of active form of vitamin d_ of improved stability
11/26/1996CA1338737C Porphyrins and cancer treatment
11/26/1996CA1338736C Microcrystals containing an active ingredient with affinity for phospholipids and at least one phospholipid; process for preparing the same
11/25/1996EP0742022A4 Biologically compatible hydrogel
11/24/1996CA2177115A1 Methods for inhibiting bone loss
11/21/1996WO1996036709A1 Transforming growth factor alpha hii
11/21/1996WO1996036704A1 Methods of use of phthalocyanines to inactivate blood borne parasites
11/21/1996WO1996036639A1 Amidine derivatives useful as anti-platelet aggregation inhibitors and vasodilators
11/21/1996WO1996036638A1 Xanthines and their therapeutic use
11/21/1996WO1996036632A1 Pyrrolidinyl methyl indole salt
11/21/1996WO1996036630A1 Tetralin compounds with mdr activity
11/21/1996WO1996036628A1 6-carboxamido dihydropyran derivatives
11/21/1996WO1996036626A1 Cyclohexyl dihydrobenzofuranes
11/21/1996WO1996036625A1 Phenyl dihydrobenzofuranes
11/21/1996WO1996036623A1 Diaryl-5-oxygenated-2-(5h)-furanones as cox-2 inhibitors
11/21/1996WO1996036622A1 10-deacetyl-14beta-hydroxybaccatine iii derivatives, a process for the preparation thereof and formulations containing them
11/21/1996WO1996036620A1 Diaryldiamine derivatives and their use as delta opioid (ant)-agonists
11/21/1996WO1996036617A1 Substituted oxazoles for the treatment of inflammation
11/21/1996WO1996036612A1 Tribenzimidazoles useful as topoisomerase i inhibitors
11/21/1996WO1996036609A1 Quinolyl-ethynyl derivatives having retinoid-like activity
11/21/1996WO1996036608A1 α,β-UNSATURATED KETONE DERIVATIVES
11/21/1996WO1996036599A1 Cyclopentane heptan(ene)oic acid, 2-heteroarylalkenyl derivatives as therapeutic agents for the treatment of ocular hypertension
11/21/1996WO1996036584A1 Process for resolving chiral acids with 1-aminoindan-2-ols
11/21/1996WO1996036583A1 Novel ether compound and process for producing the same
11/21/1996WO1996036361A1 Dna binding antibodies
11/21/1996WO1996036351A1 Use of ribavirin and interferon alpha for the treatment of hepatitis c
11/21/1996WO1996036348A1 Pharmaceutical and/or dietetic compositions with antioxidant activity containing carnosine or derivatives and branched amino acids
11/21/1996WO1996036347A1 Use of leukotriene antagonists for alzheimer's disease
11/21/1996WO1996036341A1 Use of a glucan structure compound for inhibiting antibodies and method for obtaining same
11/21/1996WO1996036339A2 Use of dihydrotestosterone compounds for treating male sexual dysfunction
11/21/1996WO1996036338A1 Bisacodyl dosage form for colonic delivery
11/21/1996WO1996036337A1 New use
11/21/1996WO1996036336A1 New pharmacological use of aii-receptor antagonists
11/21/1996WO1996036335A1 Terpenoidic derivatives (sarcodictyins) useful as antitumor agents
11/21/1996WO1996036334A1 Use of calcium intracellular store inactivators and formulations thereof as cell growth inhibitors
11/21/1996WO1996036333A1 Methods for inhibiting bone loss
11/21/1996WO1996036332A1 Use of forskolin or extracts containing it in the manufacture of a medicament for the treatment of alcohol addiction
11/21/1996WO1996036331A1 Method of treating endotoxic shock
11/21/1996WO1996036330A2 Compositions containing fatty acids for improving digestion and absorption in the small intestine
11/21/1996WO1996036329A1 Treatment of inflammatory bowel disease using oral dosage forms of omega-3 polyunsaturated acids
11/21/1996WO1996036328A1 A method of treatment of mania and bipolar disorder
11/21/1996WO1996036327A1 Method of modulating microcirculation
11/21/1996WO1996036325A1 Agents for reducing weight
11/21/1996WO1996036324A2 Use of a pharmaceutically acceptable oxalate derivative in the manufacture of a medicament for the treatment of skin conditions
11/21/1996WO1996036323A1 Cosmetic make-up compositions
11/21/1996WO1996036322A1 Pharmaceutical dosage form with multiple enteric polymer coatings for colonic delivery
11/21/1996WO1996036321A1 Bisacodyl dosage form with multiple enteric polymer coatings for colonic delivery
11/21/1996WO1996036318A2 Three-phase pharmaceutical form with constant and controlled release of amorphous active ingredient for single daily application
11/21/1996WO1996036317A1 Production scale method of forming microparticles
11/21/1996WO1996036314A2 Method for drug delivery to the pulmonary system
11/21/1996WO1996036311A1 Use of glyceryl triacetate for treating onychomycoses
11/21/1996WO1996036272A1 Controlled application of select ophthalmic agents and controlled disinfecting of multiple use articles
11/21/1996WO1996036243A1 Glucogenic compound
11/21/1996WO1996036230A1 Modulators for new members of the steroid/thyroid superfamily of receptors
11/21/1996WO1996036222A2 Improved method for controlling ectoparasites
11/21/1996WO1996027375A3 Use of dextromethorphan or dextrorphan for the treatment of urinary incontinence
11/21/1996WO1996026712A3 Use of angiogenesis suppressors for inhibiting hair growth
11/21/1996WO1996025169A3 Non-anticoagulant heparinoids for treating hypovolemic shock
11/21/1996DE19518262A1 Die Verwendung von Glyceryltriacetat zur Behandlung von Onychomykosen The use of glyceryl triacetate for the treatment of onychomycosis
11/21/1996DE19518254A1 Agent for rapidly elevating the blood sugar levels in diabetics
11/21/1996CA2221716A1 Methods of use of phthalocyanines to inactivate blood borne parasites
11/21/1996CA2221692A1 Substituted oxazoles for the treatment of inflammation
11/21/1996CA2221464A1 Cosmetic make-up compositions
11/21/1996CA2221380A1 Diaryldiamine derivatives and their use as delta opioid (ant)-agonists
11/21/1996CA2221375A1 Process for resolving chiral acids with 1-aminoindan-2-ols
11/21/1996CA2221357A1 Phenyl dihydrobenzofuranes
11/21/1996CA2221351A1 Cyclohexyl dihydrobenzofuranes
11/21/1996CA2221314A1 Use of ribavirin and interferon alpha for the treatment of hepatitis c
11/21/1996CA2221248A1 Tribenzimidazoles useful as topoisomerase i inhibitors
11/21/1996CA2221131A1 Quinolyl-ethynyl derivatives having retinoid-like activity
11/21/1996CA2220754A1 6-carboxamido dihydropyran derivatives
11/21/1996CA2220687A1 Use of a pharmaceutically acceptable oxalate derivative in the manufacture of a medicament for the treatment of skin conditions
11/21/1996CA2220549A1 Amidine derivatives useful as anti-platelet aggregation inhibitors and vasodilators
11/21/1996CA2220451A1 Methods and compositions for improving digestion and absorption in the small intestine
11/21/1996CA2219752A1 Tetralin compounds with mdr activity
11/21/1996CA2219395A1 New pharmacological use of aii-receptor antagonists
1 ... 6857 6858 6859 6860 6861 6862 6863 6864 6865 6866 6867 6868 6869 6870 6871 6872 6873 6874 6875 6876 6877 ... 7860